Marit Otterlei

Gründer bei APIM Therapeutics AS

61 Jahre

Consumer Services

Government

Health Technology

Aktive Positionen von Marit Otterlei

Unternehmen	Position	Beginn	Ende
APIM Therapeutics AS APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2009	-
	Gründer	01.01.2009	-
Norwegian University of Science & Technology	Corporate Officer/Principal	-	-
The Norwegian Academy of Science & Letters The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway.	Corporate Officer/Principal	01.01.2006	-

Unternehmen	Position	Beginn	Ende
Noregs forskingsråd	Direktor/Vorstandsmitglied	01.01.2005	-

Norwegian University of Science & Technology

Graduate Degree

International

Norwegen

Operativ

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1
Founder	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	3
Noregs forskingsråd	Government
APIM Therapeutics AS APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway.	Health Technology
The Norwegian Academy of Science & Letters The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway.	Commercial Services